Evaluation of Liver Changes in Type-2 Diabetes Mellitus Patients using Computed Tomography

Liver Changes in Type-2 Diabetes Mellitus Patients using Computed Tomography


  • Nayyar Ashfaq University Institute of Radiological and Medical Imaging Sciences, The University of Lahore, Gujrat Campus
  • Akash John University Institute of Radiological and Medical Imaging Sciences, The University of Lahore, Gujrat Campus
  • Abid Ali Department of Allied Health Sciences, The University of Lahore, Gujrat Campus
  • Amina Sharif Bhatti University Institute of Radiological and Medical Imaging Sciences, The University of Lahore, Gujrat Campus
  • Hateem Qaiser University Institute of Radiological and Medical Imaging Sciences, The University of Lahore, Gujrat Campus




Fatty liver disease, Diabetes mellitus , Hypertension, Computed tomography


There is an association between hypertension, non-alcoholic fatty liver, and diabetes mellitus. Diabetic patients commonly have fatty liver and heart problems. Objective: To evaluate the adverse effects of diabetes on the liver, and to determine the association between diabetes and metabolic associated fatty liver disease using Computed Tomography. Methods: It was a cross-sectional study conducted on 50 diabetic patients using convenient sampling method. The research was carried out in CT Department of Radiology of Tertiary care hospital in Gujranwala, Pakistan. Males and females between the ages of 30-80 who had undergone abdominal CT scans were included in this study. A written consent form was also signed by patients. This study was conducted over 4 months from December 2021 to March 2022. Data were entered and analyzed using SPSS version 20.0. Results: The current study revealed that male diabetic patients have more chances to have non-alcoholic fatty liver disease 33(66%) than females 17(34%). The diabetic patients of in senior age group (50-60) years were most commonly affected by 27(54%) with metabolic-associated fatty liver disease. According to findings diabetic patients frequently had fatty liver disease 22(44%) and fatty liver disease along with cardiovascular disease was 11(22%). Some other findings with less occurrence of non-alcoholic fatty liver disease were hypertension and hyperlipidemia 7(14%). Conclusion: In conclusion, diabetic patients are more common to be related with fatty liver disease. There was strong connection between diabetes mellitus and fatty liver disease. Elderly patients are more commonly affected.


Haligur M, Topsakal S, Ozmen O. Early degenerative effects of diabetes mellitus on pancreas, liver, and kidney in rats: an immunohistochemical study. Experimental diabetes research. 2012; 2012:120645. doi: 10.1155/2012/120645.

Lai R-M, Chen T-B, Hu Y-H, Wu G, Zheng Q. Effect of type 2 diabetic Mellitus in the prognosis of acute-on-chronic liver failure patients in China. World Journal of Gastroenterology. 2021 Jun; 27(23):3372-3385. doi: 10.3748/wjg.v27.i23.3372.

Song T, Jia Y, Li Z, Wang F, Ren L, Chen S. Effects of liraglutide on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Therapy. 2021 Jun; 12(6):1735-1749. doi: 10.1007/s13300-021-01072-4.

Besutti G, Bonilauri L, Manicardi E, Venturelli F, Bonelli E, Monelli F, et al. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study. Diabetes Research and Clinical Practice. 2021 Jul; 177:108882. doi: 10.1016/j.diabres.2021.108882.

Unsal İO, Calapkulu M, Sencar ME, Cakal B, Ozbek M. Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease. Scientific Reports. 2022 Jan; 12(1):283. doi: 10.1038/s41598-021-04361-x.

Tariq R, Axley P, Singal AK. Extra-hepatic manifestations of nonalcoholic fatty liver disease: a review. Journal of clinical and experimental hepatology. 2020 Jan-Feb;1 0(1):81-87. doi: 10.1016/j.jceh.2019.07.008.

Silaghi CA, Silaghi H, Craciun AE, Farcas A, Colosi HA, Cosma DT, et al. Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. Medical ultrasonography. 2015 Sep; 17(3):300-7. doi: 10.11152/mu.2013.2066.173.cas.

Tan L, Chen L, Jia Y, Li L, Wang J, Huang X, et al. Impact of diabetes mellitus on short-term prognosis, length of stay, and costs in patients with acute kidney injury: A nationwide survey in China. Plos one. 2021 May; 16(5):e0250934. doi: 10.1371/journal.pone.0250934.

Sakharkar P, Deb S. Examining Liver Function in Adults with Diabetes in the United States. Journal of Pharmacy & Pharmaceutical Sciences. 2021; 24:317-328. doi: 10.18433/jpps31851.

Fortes PC, de Moraes TP, Mendes JG, Stinghen AE, Ribeiro SC, Pecoits-Filho R. Insulin resistance and glucose homeostasis in peritoneal dialysis. Peritoneal Dialysis International. 2009 Feb; 29 Suppl 2:S145-8. doi.org/10.1177/089686080902902S28

Koutnikova H, Genser B, Monteiro-Sepulveda M, Faurie J-M, Rizkalla S, Schrezenmeir J, et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease-related variables: a systematic review and meta-analysis of randomized controlled trials. British Medical Journal Open. 2019 Mar; 9(3):e017995. doi: 10.1136/bmjopen-2017-017995.

Singh SP, Singh A, Pati GK, Misra B, Misra D, Kar SK, et al. A study of the prevalence of diabetes and prediabetes in patients of non-alcoholic fatty liver disease and the impact of diabetes on liver histology in coastal Eastern India. Journal of diabetes mellitus. 2014; 4(04):290. doi.org/10.4236/jdm.2014.44040

Khodami B, Hatami B, Yari Z, Alavian SM, Sadeghi A, Varkaneh HK, et al. Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial. European Journal of Clinical Nutrition. 2022 Jul; 76(7):987-994. doi: 10.1038/s41430-022-01081-x.

Bril F, Cusi K. Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action. Diabetes Care. 2017 Mar; 40(3):419-430. doi: 10.2337/dc16-1787.

Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Annals of the New York Academy of Sciences. 2013 Apr;1281(1):106-22. doi: 10.1111/nyas.12016.

Lee DH. Noninvasive evaluation of nonalcoholic fatty liver disease. Endocrinology and Metabolism. 2020 Jun; 35(2):243-259. doi: 10.3803/EnM.2020.35.2.243.

Mohammed Z. Characterization of Non-alcoholic Fatty Liver Diseases using computed Tomography: Sudan University of Science and Technology; 2020.

Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nature Reviews Endocrinology. 2022 Jan; 18(1):55-66. doi: 10.1038/s41574-021-00584-0.

Lamos EM, Kristan M, Siamashvili M, Davis SN. Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease. Expert review of clinical pharmacology. 2021 Jul; 14(7):837-52. doi: 10.1080/17512433.2021.1917374.

Heo S, Kim DW, Choi SH, Kim SW, Jang JK. Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis. European radiology. 2022 May; 32(5):3377-87. doi: 10.1007/s00330-021-08436-1.

Chandan S, Mohan BP, Khan SR, Facciorusso A, Ramai D, Kassab LL, et al. Efficacy and safety of intragastric balloon (IGB) in non-alcoholic fatty liver disease (NAFLD): a comprehensive review and meta-analysis. Obesity Surgery. 2021 Mar; 31(3):1271-9. doi: 10.1007/s11695-020-05084-0.

Pastori D, Pani A, Di Rocco A, Menichelli D, Gazzaniga G, Farcomeni A, et al. Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis. British Journal of Clinical Pharmacology. 2022 Feb; 88(2):441-51. doi: 10.1111/bcp.14943.

Cao Q, Yan C, Han X, Wang Y, Zhao L. Quantitative Evaluation of Nonalcoholic Fatty Liver in Rat by Material Decomposition Techniques using Rapid-switching Dual Energy CT. Academic Radiology. 2022 Jun; 29(6):e91-e97. doi: 10.1016/j.acra.2021.07.027.

Tatikonda VK, Gorrela VP, Racherla A. Role of Triple Phase Computed Tomography in the Evaluation of Liver Lesions. 2021. doi.org/10.7860/IJARS/2021/48188.2644

Abd El-Kader SM, El-Den Ashmawy EMS. Non-alcoholic fatty liver disease: The diagnosis and management. World journal of hepatology. 2015 Apr; 7(6):846-58. doi: 10.4254/wjh.v7.i6.846.

Osama H, Siddig A, Gareeballah A, Gameraddin M, Osman HE. Evaluation of Liver in Type 2 Diabetes Mellitus Using Unenhanced Computed Tomography. International Journal of Biomedicine. 2020;10(4):402-6. DOI: 10.21103/Article10(4)_OA14

Hegazy M, Elsayed NM, Ali HM, Hassan HG, Rashed L. Diabetes mellitus, nonalcoholic fatty liver disease, and conjugated linoleic acid (omega 6): what is the link?. Journal of Diabetes Research. 2019 Apr; 2019. doi.org/10.1155/2019/5267025

Bayazed AR. Study of Liver Changes in Diabetic Patients using Computed Tomography (Doctoral dissertation, Sudan University of Science and Technology). 2019.



DOI: 10.54393/df.v3i1.45
Published: 2022-06-30

How to Cite

Ashfaq, N. ., John, A. ., Ali, A. ., Sharif Bhatti, A. ., & Qaiser, H. . (2022). Evaluation of Liver Changes in Type-2 Diabetes Mellitus Patients using Computed Tomography: Liver Changes in Type-2 Diabetes Mellitus Patients using Computed Tomography. DIET FACTOR (Journal of Nutritional and Food Sciences), 3(1), 14–18. https://doi.org/10.54393/df.v3i1.45



Original Article